A SENSITIVE ELISA FOR VON WILLEBRAND FACTOR (VWF-AG)

被引：0
|
作者：
INGERSLEV, J [1 ]
机构：
[1] AARHUS UNIV HOSP,DEPT CLIN IMMUNOL,DK-8000 AARHUS C,DENMARK
来源：
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION | 1987年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：143 / 149
页数：7
相关论文
共 50 条
  • [31] Platelet von Willebrand factor (VWF) MRNA analysis in patients with von Willebrand disease (VWD) and null mutations in VWF gene
    Giacomelli, S.
    Rodeghiero, F.
    Castaman, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 839 - 839
  • [32] SEQUENTIAL STUDIES OF NEOPTERIN, VON-WILLEBRAND-FACTOR ANTIGEN (VWF-AG) CREATINE-KINASE NCK) AND ALDOLASE IN JUVENILE DERMATOMYOSITIS (JDMS) - CORRELATES OF DISEASE-ACTIVITY
    PACHMAN, LM
    DILLING, D
    LITT, D
    MILLER, ML
    SINACORE, JS
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S257 - S257
  • [33] Course of von Willebrand factor (VWF) during pregnancy in women with von Willebrand disease (VWD)
    von Depka, M.
    Detering, C.
    Henkel-Klene, A.
    Doepke, S.
    von Depka, E.
    Ekhlasi-Hundrieser, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 500 - 500
  • [34] Effects of Elevated Levels of Fibrinogen, Factor VIII, and VON Willebrand Factor (VWF Antigen, VWF: Ag, and VWF) on the Innovance® PFA P2Y Cartridge
    McGlasson, David L.
    Shah, Anand D.
    Fritsma, George A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S166 - S167
  • [35] Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo
    Geisen, Ulrich
    Zieger, Barbara
    Nakamura, Lea
    Weis, Andreas
    Heinz, Juergen
    Michiels, Jan Jacques
    Heilmann, Claudia
    THROMBOSIS RESEARCH, 2014, 134 (02) : 246 - 250
  • [36] Analysis of factor VIII:c/VWF:Ag ratio in the Brno-von Willebrand disease study
    Vangenechten, I
    Smejkal, P.
    Zapletal, O.
    Bouddount, F.
    Zavrelova, J.
    Blatny, J.
    Penka, M.
    Michiels, J. J.
    Gadisseur, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 549 - 549
  • [37] The role of VWF:Ag II in patients with acquired von Willebrand disease
    Krause, M
    Caron, C
    Stier-Brück, I
    Vigh, T
    Scharrer, I
    34th Hemophilia Symposium, 2005, : 207 - 211
  • [38] The von Willebrand factor propolypeptide, von Willebrand antigen II (vWAgII), distinguishes acquired von Willebrand syndrome (AvWS) due to decreased synthesis of von Willebrand factor (vWF) from AvWS due to increased clearance of vWF.
    Scott, JP
    Vokac, EA
    Schroeder, T
    Foster, PA
    Gill, JC
    Montgomery, PR
    BLOOD, 1995, 86 (10) : 773 - 773
  • [39] ELECTROIMMUNOASSAY OF VWF-AG - INCREASED SENSITIVITY WITH ENZYME ENHANCEMENT
    HAN, P
    TEO, SH
    WONG, HB
    THROMBOSIS RESEARCH, 1987, 47 (01) : 113 - 116
  • [40] Assays for von Willebrand factor (VWF): A need for further standardisation?
    Jennings, Ian
    Brown, Lilia
    Kitchen, Dianne
    Kitchen, Steve
    Woods, Timothy
    Walker, Isobel
    HAEMOPHILIA, 2018, 24 : 45 - 45
12345